SCHEMBL2649962

SCHEMBL2649962

CSc1sc(NC(=O)Nc2cnccc2C(=O)C2CCCC2)nc1C(=O)OC(=O)c1nc(NC(=O)Nc2ccncc2C(=O)C2CCCC2)sc1SC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNE1 P24864 3/20 0.36
CDK2 P24941 3/20 0.36
CDK5 Q00535 3/20 0.36
MAPT P10636 4/20 0.33
GSK3B P49841 3/20 0.33
ALDH1A1 P00352 3/20 0.33
ABL1 P00519 4/20 0.32
KIT P10721 1/20 0.31
PDGFRA P16234 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
GAA P10253 1/20 0.31
KDM4C Q9H3R0 2/20 0.31
TSHR P16473 1/20 0.31
HSD17B10 Q99714 1/20 0.31
PDE4A P27815 1/20 0.30
PDE4B Q07343 1/20 0.30
PDE4C Q08493 1/20 0.30
PDE4D Q08499 1/20 0.30
CNR1 P21554 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2649953 0.91 CCNE1 (0.37) CCNE1CDK2CDK5MAPTGSK3B
SCHEMBL1341881 0.88 CCNE1 (0.39) CCNE1CDK2CDK5ABL1KIT
SCHEMBL1341634 0.87 CCNE1 (0.39) CCNE1CDK2CDK5MAPTGSK3B
SCHEMBL1343840 0.81 CCNE1 (0.37) CCNE1CDK2CDK5ABL1RAB9A
SCHEMBL1339883 0.80 CCNE1 (0.38) CCNE1CDK2CDK5MAPTGSK3B
SCHEMBL1342923 0.79 CCNE1 (0.36) CCNE1CDK2CDK5MAPTABL1
SCHEMBL2650013 0.78 KDM4C (0.34) CCNE1CDK2CDK5ALDH1A1RAB9A
SCHEMBL1342097 0.78 CCNE1 (0.36) CCNE1CDK2CDK5MAPTGSK3B
SCHEMBL1341605 0.77 CCNE1 (0.37) CCNE1CDK2CDK5MAPTALDH1A1
SCHEMBL1342177 0.77 CCNE1 (0.46) CCNE1CDK2CDK5RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1531815-A1 GLUCOKINASE ACTIVATORS NOVO NORDISK A/S (DK) 2005-05-25 EP disclosed
WO-2004002481-A1 ARYL CARBONYL DERIVATIVES AS THERAPEUTIC AGENTS NOVO NORDISK A/S (DK) 2004-01-08 WO disclosed